X

Blog

Lift Events & Experiences to Bring Unique Cannabis Conference, Trade Show and Associated Opportunities to the U.S. Cannabis Market

Become a part of the 2023 U.S. debut of Lift Events & Experiences, at the Moscone Center in San Francisco,…

QualityStocks

QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) to Participate in Upcoming One-on-One Investor Conference

FingerMotion (NASDAQ: FNGR) CEO Martin Shen is scheduled to participate in one-on-one meetings during the Benchmark Company’s 11th annual Discovery…

QualityStocks

CubCrafters Inc. Sees Increased Investor Interest as it receives Reg A Qualification by the SEC; Company Production Currently Sold Out Through Late-2024

CubCrafters’ announcement about filing for Reg A qualification with the SEC was met with enthusiasm as investors pledged $5 million…

QualityStocks

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Q3 2022 Financial Results

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, released its financial and…

QualityStocks

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Featured in Recent Power Play Interview

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and…

QualityStocks

REZYFi, Inc. Leverages Growth of California’s Cannabis Market as It Expands to Include Social Equity Provisions, More Opportunities for Business Owners

California retail stores sold almost $5.3 billion worth of cannabis products in 2021 and reported a total tax revenue of…

QualityStocks

SideChannel Inc. (SDCH) Simplifies Cybersecurity by Matching SMBs with Virtual Chief Information Security Officers to Reduce Internal Costs

Cyberattacks on SMBs have increased due to the changing network landscape due to the increase in remote and in-office workers…

QualityStocks

European Clinical Trial Site Expansion for CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Brain Cancer Drug Candidate Drives Patient Enrollment

U.S.-based drug innovator CNS Pharmaceuticals is continuing to advance its global human clinical trial for Berubicin, a potentially pivotal treatment…

QualityStocks

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Seeking to Solve Unmet Need for GBM Treatment

CNS Pharmaceuticals (NASDAQ: CNSP) is an oncology drug development company specializing in developing anti-cancer drugs for the treatment of primary…

QualityStocks

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Bridging Gap Between Lidar Concept and Deployment with NVIDIA DRIVE Sim(TM)

Cepton (NASDAQ: CPTN) recently teamed up with NVIDIA to add its lidars into NVIDIA DRIVE Sim(TM) – an end-to-end simulation…

QualityStocks